Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients
Recruiting
- Conditions
- Threatened Preterm LaborPreterm BirthPreTerm Labor
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- PreTeL, Inc
- Target Recruit Count
- 181
- Registration Number
- NCT06157203
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸Dume University Medical Center, Durham, North Carolina, United States
Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions
Early Phase 1
- Conditions
- Pregnancy RelatedLabor LongFetal Distress
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- PreTeL, Inc
- Target Recruit Count
- 51
- Registration Number
- NCT04548453
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Multichannel EMG Diagnosing True Preterm Labor
Completed
- Conditions
- Labor; IrregularPreterm LaborPregnancy Preterm
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- PreTeL, Inc
- Target Recruit Count
- 23
- Registration Number
- NCT03785795
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
News
No news found